Adidas poaches global brand chief from Paris-based TBWA agency

Sportswear giant Adidas has appointed Nicholas Baddour as head of global brand advertising, following the departure of Neil Simpson.

Baddour joins from Paris-based agency BDDP & Fils – a French subsidiary of Adidas’s global advertising agency TBWA – where he was an associate partner. He takes up his new position on October 1, reporting to head of global marketing Erich Stamminger.

Simpson, who claims to be leaving for personal reasons, is believed to be returning to the UK to take up a senior marketing position. Simpson has been with Adidas since 1997 and oversaw last year’s advertising review, which resulted in Leagas Delaney being taken off the &£70m account. He retained TBWA Worldwide and added Amsterdam-based agency 180 to the roster. (MW January 4).

Simpson is returning to the UK after almost eight years abroad. He spent two years at Coca-Cola in the US and has been based in Amsterdam with Adidas for almost six years.

Adidas recently announced plans to launch a designer footwear and clothing range called Sports Style. The company expects the range to account for five per cent of total sales over the next five to ten years.

Recommended

Troubled Parcelforce hands ad brief to Soup

Marketing Week

Parcelforce has appointed Soup to handle its consolidated advertising and direct marketing business, after a six-way pitch. The budget for the account is between £1.5m and £3.5m. Soup, which was the incumbent on the direct marketing business, pitched against Draft Worldwide London, Joshua, Interfocus, Perspectives Red Cell and Proximity London (MW July 25). Lowe had […]

OTC regulatory body reviews ad regulations

Marketing Week

The Proprietary Association of Great Britain (PAGB), the trade body for over-the-counter (OTC) medicines and food supplements, is set to revise its advertising code. The move is thought to have been prompted by the growing number of medicines switching from being prescription-only medicines (POM) to OTC. Levonelle, Schering Health Care’s morning-after pill which recently switched […]